<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ETF Trends &#187; PBE</title>
	<atom:link href="http://www.etftrends.com/tag/pbe/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.etftrends.com</link>
	<description>Setting the Pace for Exchange Traded Funds</description>
	<lastBuildDate>Sun, 12 Feb 2012 11:00:32 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Biotech ETFs Mixed After Gilead Subpoena</title>
		<link>http://www.etftrends.com/2011/06/biotech-etfs-mixed-after-gilead-subpoena/</link>
		<comments>http://www.etftrends.com/2011/06/biotech-etfs-mixed-after-gilead-subpoena/#comments</comments>
		<pubDate>Mon, 13 Jun 2011 17:53:52 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[BBH]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[PBE]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=56144</guid>
		<description><![CDATA[Biotechnology exchange traded funds were mixed Monday after sector bellwether Gilead Sciences (NasdaqGS: GILD) disclosed it has received a subpoena from the U.S. Department of Justice.
Gilead shares were down nearly 1% but pared their earlier loss after the company late Friday said it has received a request for information from the U.S. Attorney&#8217;s Office for [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/06/biotech-etfs-mixed-after-gilead-subpoena/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>5 Biotechnology ETFs to Play Innovation</title>
		<link>http://www.etftrends.com/2011/02/5-biotechnology-etfs-play-innovation/</link>
		<comments>http://www.etftrends.com/2011/02/5-biotechnology-etfs-play-innovation/#comments</comments>
		<pubDate>Tue, 22 Feb 2011 22:00:10 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[BBH]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[FBT]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[HOLDRs]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[XBI]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=46796</guid>
		<description><![CDATA[While the broader market has picked up its pace, the biotechnology sector has not seen a similar surge in performance. Still, investors should keep in mind the various biotech exchange traded fund (ETF) plays to stay positioned for a resurgence in the sector.
Currently, the biotech industry is full of fast-growing and very profitable companies; however, [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2011/02/5-biotechnology-etfs-play-innovation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why Health Care ETFs May Be In the Clear</title>
		<link>http://www.etftrends.com/2010/11/why-health-care-etfs-may-be-in-the-clear/</link>
		<comments>http://www.etftrends.com/2010/11/why-health-care-etfs-may-be-in-the-clear/#comments</comments>
		<pubDate>Wed, 10 Nov 2010 19:00:49 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Long-Short ETFs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[FBT]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[IHF]]></category>
		<category><![CDATA[IXJ]]></category>
		<category><![CDATA[IYH]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[PJP]]></category>
		<category><![CDATA[PTH]]></category>
		<category><![CDATA[RXD]]></category>
		<category><![CDATA[RXL]]></category>
		<category><![CDATA[RYH]]></category>
		<category><![CDATA[VHT]]></category>
		<category><![CDATA[XBI]]></category>
		<category><![CDATA[XLV]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=40871</guid>
		<description><![CDATA[After the Democrats lost some seats in the mid-term elections, you might be wondering whether health care revenue and exchange traded funds (ETFs) will be affected by the shift. Some don&#8217;t believe there&#8217;s anything to worry about for a while.
First, with most corporations backing major Congressional players, it is almost certain that the medical industry [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/11/why-health-care-etfs-may-be-in-the-clear/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>5 Things That Drive Biotech ETFs</title>
		<link>http://www.etftrends.com/2010/10/5-things-drive-biotech-etfs/</link>
		<comments>http://www.etftrends.com/2010/10/5-things-drive-biotech-etfs/#comments</comments>
		<pubDate>Thu, 21 Oct 2010 22:00:55 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Long-Short ETFs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[BIB]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[FBT]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[XBI]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=39693</guid>
		<description><![CDATA[The biotechnology sector is a unique one because many of the companies that compose it are not yet profitable. Here&#8217;s what drives the sector and exchange traded funds (ETFs) that let you play it.
Kashif Javed for Forex Trading Analysis reports that the biotech sector is driven by and dependent on several key things:

Mergers and acquisitions: [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/10/5-things-drive-biotech-etfs/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotech ETFs:The Better Way to Play</title>
		<link>http://www.etftrends.com/2010/10/biotech-etfsbetter-way-play/</link>
		<comments>http://www.etftrends.com/2010/10/biotech-etfsbetter-way-play/#comments</comments>
		<pubDate>Mon, 11 Oct 2010 13:00:22 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[FBT]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[XBI]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=38873</guid>
		<description><![CDATA[As cash-strapped biotech companies see their cash reserves dwindle, it  has forced a number of companies to close up shop. The struggles faced in the sector highlights the benefits of getting exposure to it through biotech exchange traded funds (ETFs).
The number of publicly-traded U.S. biotech companies has diminished by 25% since 2007, writes Brett Chase [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/10/biotech-etfsbetter-way-play/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotech ETFs: 5 Ways to Play Innovation</title>
		<link>http://www.etftrends.com/2010/08/biotech-etfs-5-ways-play-innovation/</link>
		<comments>http://www.etftrends.com/2010/08/biotech-etfs-5-ways-play-innovation/#comments</comments>
		<pubDate>Sun, 08 Aug 2010 20:00:05 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[BBH]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[FBT]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[XBI]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=34724</guid>
		<description><![CDATA[Biotechnology has been improving our quality of life for generations. The industry does everything from researching a cure for cancer to finding disease-resistant crops and more. While this can be a difficult sector in which to invest, there are five exchange traded funds (ETFs) that make it easier.
The biotech industry utilizes cellular and biomolecular processes [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/08/biotech-etfs-5-ways-play-innovation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>5 Biotech ETFs If You&#8217;re Bullish</title>
		<link>http://www.etftrends.com/2010/06/5-biotech-etfs-if-youre-bullish/</link>
		<comments>http://www.etftrends.com/2010/06/5-biotech-etfs-if-youre-bullish/#comments</comments>
		<pubDate>Fri, 25 Jun 2010 08:00:09 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Featured]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[BBH]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[FBT]]></category>
		<category><![CDATA[Feature Stories]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[Hot Story]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[XBI]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=31834</guid>
		<description><![CDATA[Biotechnology has helped improve the lives of many people. Naturally, many biotech stocks boom or bust based on the success of products in their pipeline. But if you’re looking for a more diversified and steady approach to biotech investing, look no further than exchange traded funds (ETFs).
Matthew D. McCall of Index Universe is bullish on [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/06/5-biotech-etfs-if-youre-bullish/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotech ETFs: Where the Future Lies</title>
		<link>http://www.etftrends.com/2010/02/biotech-etfs-where-future-lies/</link>
		<comments>http://www.etftrends.com/2010/02/biotech-etfs-where-future-lies/#comments</comments>
		<pubDate>Fri, 05 Feb 2010 22:00:21 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[FBT]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[XBI]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=24829</guid>
		<description><![CDATA[Biotechnology is continuously advancing and the future may lie in personalized medicine. The biotech sector, along with related exchange traded funds (ETFs), may see billions in revenue as this market grows in the coming years.
Biotech companies, investors, providers and big pharmaceutical giants are bullish on personalized medicine and have readily entered the field, writes Rebecca [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2010/02/biotech-etfs-where-future-lies/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotechnology: Why ETFs Suit the Sector</title>
		<link>http://www.etftrends.com/2009/11/biotechnology-why-etfs-suit-sector/</link>
		<comments>http://www.etftrends.com/2009/11/biotechnology-why-etfs-suit-sector/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 22:00:10 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[XBI]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=20989</guid>
		<description><![CDATA[ The biotechnology sector is once again finding its footing, with some exchange traded funds (ETFs) focused on the sector up more than 30% since the market&#8217;s March 9 low. But there have been stumbling blocks on the way back to profitability.
A reputable biotechnology company has filed for Chapter 11 this week, deCODE Genetics Inc [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/11/biotechnology-why-etfs-suit-sector/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What Biotechnology ETFs Need to Thrive</title>
		<link>http://www.etftrends.com/2009/09/what-biotechnology-etfs-need-thrive/</link>
		<comments>http://www.etftrends.com/2009/09/what-biotechnology-etfs-need-thrive/#comments</comments>
		<pubDate>Fri, 04 Sep 2009 21:00:53 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[XBI]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=16983</guid>
		<description><![CDATA[ The biotechnology sector and its related exchange traded funds (ETFs) have seen a handsome rebound off the March 9 lows, but does the cash-strapped sector have what it takes to survive for the long haul?
Analysts estimate that nearly half of all biotechnology firms have insufficient cash on hand to last them one year. As [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/09/what-biotechnology-etfs-need-thrive/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>7 Reasons Biotechnology ETFs Could Succeed</title>
		<link>http://www.etftrends.com/2009/08/7-reasons-biotechnology-etfs-could-succeed/</link>
		<comments>http://www.etftrends.com/2009/08/7-reasons-biotechnology-etfs-could-succeed/#comments</comments>
		<pubDate>Thu, 06 Aug 2009 08:00:46 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[PBE]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=14887</guid>
		<description><![CDATA[The biotechnology sector and exchange traded funds (ETFs) have had a good summer so far. Some funds are up as much as 22% in the last month alone. Will it continue?
July was kind to the biotech sector. The NYSE Biotechnology Sector rose up 24%, which dwarfed the 6% for the S&#38;P 500. Sam Subramanian for [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/08/7-reasons-biotechnology-etfs-could-succeed/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ETF Spotlight: PowerShares Dynamic Biotech &amp; Genome (PBE)</title>
		<link>http://www.etftrends.com/2009/07/etf-spotlight-powershares-dynamic-biotech-genome-pbe/</link>
		<comments>http://www.etftrends.com/2009/07/etf-spotlight-powershares-dynamic-biotech-genome-pbe/#comments</comments>
		<pubDate>Wed, 29 Jul 2009 21:00:52 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[ETF 101]]></category>
		<category><![CDATA[ETF Spotlight]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[Technology]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=14739</guid>
		<description><![CDATA[ETF Spotlight on PowerShares Dynamic Biotech &#38; Genome (PBE), part of a weekly series. Assets: $148 million
Holdings: This fund invests in companies involved in the biotechnology and genome sectors. Some of the top components include ImmunoGen (IMGN), Amgen (AMGN), Gilead Sciences (GILD) and Biogen (BIIB).
Objective
This fund tracks the Biotechnology &#38; Genome Intellidex Index
What&#8217;s Good

The biotechnology [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/07/etf-spotlight-powershares-dynamic-biotech-genome-pbe/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biotech Sector and ETFs Get a Lifeline</title>
		<link>http://www.etftrends.com/2009/07/biotech-sector-etfs-get-life-line/</link>
		<comments>http://www.etftrends.com/2009/07/biotech-sector-etfs-get-life-line/#comments</comments>
		<pubDate>Wed, 08 Jul 2009 19:00:11 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[FBT]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[XBI]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=13378</guid>
		<description><![CDATA[ A small piece of the 2009 Economic Stimulus Package will revamp aid to small businesses, which could give way to successful relationships between  small pharmaceutical/biotech companies and academic institutions. This may be what related investments and exchange traded funds (ETFs) need to help the industry break through. 
Challenge Grants are two years grants to National [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/07/biotech-sector-etfs-get-life-line/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Health Care Reform and Biotech ETFs: Will There Be Opportunities?</title>
		<link>http://www.etftrends.com/2009/06/health-care-reform-and-biotech-etfs-will-there-be-opportunities/</link>
		<comments>http://www.etftrends.com/2009/06/health-care-reform-and-biotech-etfs-will-there-be-opportunities/#comments</comments>
		<pubDate>Sat, 27 Jun 2009 08:00:48 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=12675</guid>
		<description><![CDATA[In an attempt to reduce costs in the health care industry, the government will be legislating for cheaper drugs, but drug makers, along with related exchange traded funds (ETFs), may see profits slip away.
The Obama administration claims that biologic drugs should be subject to generic competition after seven years, citing the potential for reducing health [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/06/health-care-reform-and-biotech-etfs-will-there-be-opportunities/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Why Biotech ETFs May Be the Better Choice</title>
		<link>http://www.etftrends.com/2009/06/why-biotech-etfs-may-be-better-choice/</link>
		<comments>http://www.etftrends.com/2009/06/why-biotech-etfs-may-be-better-choice/#comments</comments>
		<pubDate>Wed, 17 Jun 2009 18:00:12 +0000</pubDate>
		<dc:creator>Tom Lydon</dc:creator>
				<category><![CDATA[Current Affairs]]></category>
		<category><![CDATA[Sector ETFs]]></category>
		<category><![CDATA[BBH]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[FBT]]></category>
		<category><![CDATA[Health Care]]></category>
		<category><![CDATA[IBB]]></category>
		<category><![CDATA[PBE]]></category>
		<category><![CDATA[XBI]]></category>

		<guid isPermaLink="false">http://www.etftrends.com/?p=11945</guid>
		<description><![CDATA[ Biotechnology stocks present opportunities, but given the unique challenges of the sector, exchange traded funds (ETFs) may be the better route to go if you&#8217;re considering making an investment.
Owning individual biotechnology companies can be a challenging way to invest in the sector, as many of the current companies so not have enough money to [...]]]></description>
		<wfw:commentRss>http://www.etftrends.com/2009/06/why-biotech-etfs-may-be-better-choice/feed/</wfw:commentRss>
		<slash:comments>7</slash:comments>
		</item>
	</channel>
</rss>

